CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-20 | Sheena Jonathan Director | Exercise or conversion | +190 | 301,998 | ||
| 2024-07-20 | Sheena Jonathan Director | Exercise or conversion · Restricted Stock Unit | −190 | 1,142 | ||
| 2024-07-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +856 | 207,628 | ||
| 2024-07-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −856 | 5,136 | ||
| 2024-07-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −5,270 | $111.63 | $588K | 208,081 |
| 2024-07-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −226 | $112.21 | $25K | 207,855 |
| 2024-07-01 | Sheena Jonathan Director | Sale 10b5-1 | −1,793 | $108.63 | $195K | 302,715 |
| 2024-07-01 | Sheena Jonathan Director | Sale 10b5-1 | −907 | $109.33 | $99K | 301,808 |
| 2024-07-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −2,723 | $108.37 | $295K | 206,772 |
| 2024-07-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −24,008 | $107.73 | $2.6M | 226,843 |
| 2024-07-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −11,061 | $108.61 | $1.2M | 215,782 |
| 2024-07-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,431 | $109.43 | $266K | 213,351 |
| 2024-07-01 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −4,983 | $108.37 | $540K | 75,059 |
| 2024-06-28 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +5,000 | 209,495 | ||
| 2024-06-28 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −5,000 | 5,000 | ||
| 2024-06-28 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +37,500 | 250,851 | ||
| 2024-06-28 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Restricted Stock Unit 10b5-1 | −37,500 | 37,500 | ||
| 2024-06-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +12,500 | 80,042 | ||
| 2024-06-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −12,500 | 12,500 | ||
| 2024-06-28 | Williams Brinkley Ruth Director | Grant or award | +2,964 | 2,964 |
Page 70 of 85 · 1,682 trades